Dudhe SB, Ghule S. Lipid-Based Formulation of Nateglinide as a Promising Strategy for Managing Solubility Challenges in Type II Diabetes Therapy: A SMEDDS Approach. J Neonatal Surg [Internet]. 2025Jun.16 [cited 2025Oct.12];14(32S):369-77. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/7379